Emergency Medicine Doctors in Tukwila, WA Accepting Medicare

5 Emergency Medicine doctors found. Showing 1 - 5

Bev-lorraine Bergman True, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12401 E Marginal Way S, Tukwila, WA 98168 Phone: 800-337-3197    Fax: 206-901-2269

Dr. Ann-elizabeth Georgianne Jarris, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 13075 Gateway Dr S Ste 100, Tukwila, WA 98168 Phone: 206-905-4608

Jerome William Mueller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12400 E Marginal Way S, Tukwila, WA 98168 Phone: 206-901-7777

Robin Haley, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12400 E Marginal Way S, Tukwila, WA 98168 Phone: 206-901-7777

Mark Allen Lundquist, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Andover Park E Ste 8, Tukwila, WA 98188 Phone: 206-575-3136    Fax: 206-575-4892

News Archive

Oxfam interactive map shows 'food price pressure points'

A new interactive map from Oxfam "shows how poor communities across the world are being hurt by high and volatile food prices. This 'food price pressure points map' provides a global snapshot of the impacts of the global food price crisis," according to the website.

Cerus enters into collaborative agreement with EFS for development of INTERCEPT Blood System

Cerus Corporation announced today that it has entered into a collaborative agreement with France's national transfusion service, the Etablissement Français du Sang (EFS), for the development of the company's INTERCEPT Blood System for red blood cells.

Study reveals TRPV2 protein as new target for chronic pain, cancer treatments

In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length structure of a protein named Transient Receptor Potential Vanilloid subtype 2 (TRPV2).

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.

Read more Medical News

› Verified 7 days ago